2012 annual financial data
Iovance Biotherapeutics 2012 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -8,132,546 USD and net income was -3,307,619 USD.
Operating cash flow was -2,241,467 USD.
Get free Iovance Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -8,132,546 USD
- Net income
- -3,307,619 USD
- Operating cash flow
- -2,241,467 USD